ask="0.930"
ask_size="900"
average_daily_volume="645180"
bid="0.600"
bid_size="500"
book_value="0.606"
change="-0.024"
change_from_200_day_moving_average="-0.959"
change_from_50_day_moving_average="-0.136"
change_from_52_week_high="-4.074"
change_From_52_week_low="0.356"
change_in_percent="-2.727%"
close="0.856"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.237"
ebitda="-8.78M"
eps_estimate_current_year="-1.120"
eps_estimate_next_quarter="-0.250"
eps_estimate_next_year="-0.320"
ex_dividend_date="N/A"
float_shares="7029000"
high="0.890"
high_52_weeks="4.930"
last_trade_date="3/14/2017"
last_trade_price="0.856"
last_trade_size="149"
last_trade_time="3:58pm"
low="0.840"
low_52_weeks="0.500"
market_capitalization="6.11M"
moving_average_200_day="1.815"
moving_average_50_day="0.992"
name="Opexa Therapeutics
Inc."
notes="N/A"
one_year_target_price="1.000"
open="0.878"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-52.837%"
percent_change_from_50_day_moving_average="-13.685%"
percent_change_from_52_week_high="-82.637%"
percent_change_from_52_week_low="+71.200%"
previous_close="0.880"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.452"
price_per_sales="2.458"
revenue="2.56M"
shares_outstanding="7141000"
short_ratio="1.060"
stock_exchange="NCM"
symbol="OPXA"
volume="149259"
weeks_range_52="0.500 - 4.930"
